Feline Parvovirus in Cats: Symptoms, Treatment and Why Vaccination Saves Lives

Feline parvovirus (FPV) is the cause of feline panleukopenia, also known (inaccurately) as feline distemper. It is closely related to canine parvovirus type 2 (CPV-2) and belongs to the same Parvoviridae family. The name panleukopenia reflects the disease's central mechanism: destruction of all white blood cell lineages, leaving the cat profoundly immunosuppressed.

FPV targets rapidly dividing cells. In the bone marrow, it destroys precursor cells, causing the characteristic severe leukopenia. In the intestines, it attacks the crypts of Lieberkuhn, the rapidly proliferating cells that regenerate the intestinal lining. This causes the severe gastrointestinal signs of disease. In pregnant queens, FPV can cross the placenta and infect the developing fetal cerebellum, causing cerebellar hypoplasia in kittens that survive to birth.

Feline parvovirus is among the most environmentally stable viruses known in veterinary medicine. It is shed in all body secretions and excretions of infected cats, including faeces, urine, saliva, and vomit. Infected cats can shed virus for up to 6 weeks after clinical recovery.

The virus can survive in the environment for 12 months or longer under normal conditions, resisting many common disinfectants, temperature extremes, and desiccation. This persistence means that direct cat-to-cat contact is not required for transmission. Virus can be carried into a home on shoes, clothing, or hands.

In Dubai, shelters, grooming facilities, and multi-cat households carry the highest risk. Community cats with no vaccination history represent a substantial reservoir of virus in the region.

The clinical presentation of feline panleukopenia can be peracute (the cat dies before notable symptoms are observed), acute, or subacute.

In the acute form, the most common presentation is sudden onset vomiting and diarrhoea (often bloody), severe lethargy, complete anorexia, and high fever that may transition to subnormal temperature as the disease progresses. A classic clinical sign is a cat that hunches over its food or water bowl without eating or drinking, appearing drawn to the smell but too nauseated to consume anything.

In kittens under 5 weeks, the disease is almost universally fatal and rapidly progressive. In older unvaccinated cats, the course is typically 5 to 7 days from onset to either recovery (with treatment) or death.

Unvaccinated kittens under 6 months of age are at the highest risk of severe disease and death. Maternal antibodies from vaccinated queens can protect kittens for the first 6 to 14 weeks of life, but once maternal immunity wanes and before vaccination is complete, there is a susceptibility window.

Adult cats with no vaccination history (or unknown vaccine status) are also at risk. Cats from shelters, community colonies, or recently imported from other countries often fall into this category. Immunocompromised cats (FIV-positive or FeLV-positive) are at higher risk of severe disease even if previously vaccinated.

Clinical diagnosis is supported by the combination of severe leukopenia on a complete blood count, the characteristic clinical signs, and vaccination history. A total white blood cell count below 2000 cells per microlitre is strongly suggestive in an unvaccinated cat with appropriate clinical signs.

Rapid in-clinic canine parvovirus antigen tests (faecal ELISA) have been shown to have reasonable sensitivity and specificity for FPV, allowing a same-day presumptive diagnosis. PCR confirmation from faecal samples or tissue is available and is highly sensitive.

Note: recently vaccinated cats may test weakly positive on rapid antigen tests due to vaccine shedding. Context and clinical signs must be considered in interpretation.

No antiviral drug is available for FPV. Treatment is entirely supportive and must be intensive to be effective. Hospitalisation with intravenous fluid therapy is essential to correct dehydration and electrolyte imbalances caused by vomiting and diarrhoea.

Antiemetics (maropitant is preferred) reduce nausea and allow earlier nutritional support. Broad-spectrum antibiotics (typically a combination covering gram-negative and anaerobic bacteria) are given to prevent bacterial translocation across the damaged intestinal barrier. Nutritional support, either by nasogastric tube or parenteral nutrition in severe cases, is important for recovery.

Body temperature management, blood transfusion for severely anaemic cats, and intensive nursing care (warmth, hygiene, gentle handling) are all part of comprehensive management. With aggressive in-hospital treatment, survival rates of 50 to 80% are achievable in cats that reach veterinary care quickly. Without treatment, mortality exceeds 90%.

The FPV component of the PCH vaccine (Panleukopenia, Calicivirus, Herpesvirus) is one of the most effective vaccines in feline medicine. It induces robust, long-lasting immunity and is considered a core vaccine for all cats.

The primary course consists of two doses 3 to 4 weeks apart, starting at 6 to 8 weeks of age, with a booster at 12 months and then every 1 to 3 years depending on the vaccine product and individual risk assessment. Adult cats with unknown vaccine history should receive a primary course of two doses.

In Dubai, where community cats provide a continuous reservoir and the virus can persist in the warm environment, keeping cats up to date with vaccination is particularly important, even for indoor cats.